36 is the total number of securities Aisling Capital LLC has owned. The longest Aisling Capital LLC has owned a single stock is 22 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| TRXC | TRANSENTERIX INC. | 22 | 22 | 1.26% | 4.06% | 12.14% | Q2 2014 | Q3 2019 | 22 |
| CMRX | CHIMERIX INC. | 21 | 21 | 0.30% | 3.85% | 19.39% | Q4 2013 | Q4 2018 | 21 |
| ADMA | ADMA BIOLOGICS INC. | 20 | 20 | 1.83% | 7.39% | 35.46% | Q4 2014 | Q3 2019 | 20 |
| LOXO | LOXO ONCOLOGY INC. | 18 | 18 | 5.62% | 37.17% | 80.87% | Q3 2014 | Q4 2018 | 18 |
| AIMT | AIMMUNE THERAPEUTICS INC. | 17 | 17 | 7.64% | 20.66% | 68.67% | Q3 2015 | Q3 2019 | 17 |
| CDTX | CIDARA THERAPEUTICS INC. | 17 | 17 | 0.68% | 2.04% | 4.07% | Q3 2015 | Q3 2019 | 17 |
| AGRX | AGILE THERAPEUTICS INC. | 16 | 16 | 0.60% | 2.84% | 5.47% | Q2 2014 | Q1 2018 | 16 |
| ZLTQ | ZELTIQ AESTHETICS INC | 14 | 14 | 0.00% | 10.81% | 16.30% | Q2 2014 | Q3 2017 | 14 |
| ESPR | ESPERION THERAPEUTICS ... | 14 | 14 | 3.82% | 9.10% | 24.90% | Q2 2014 | Q3 2017 | 14 |
| VSAR | VERSARTIS INC | 13 | 13 | 3.66% | 6.85% | 16.16% | Q2 2014 | Q2 2017 | 13 |
| VRAY | VIEWRAY INC. | 12 | 1 | 0.00% | 6.63% | 13.68% | Q1 2016 | Q3 2019 | 13 |
| TTOO | T2 BIOSYSTEMS INC | 12 | 12 | 0.84% | 4.90% | 8.85% | Q3 2014 | Q2 2017 | 12 |
| CEMP | CEMPRA INC | 11 | 11 | 0.78% | 8.46% | 14.79% | Q2 2014 | Q4 2016 | 11 |
| PRTK | PARATEK PHARMACEUTICAL... | 11 | 11 | 1.29% | 2.21% | 3.99% | Q4 2014 | Q2 2017 | 11 |
| XENT | INTERSECT ENT INC | 11 | 11 | 0.63% | 1.12% | 1.49% | Q3 2014 | Q1 2017 | 11 |
| PERNIX THERAPEUTICS HL... | 11 | 11 | 0.01% | 0.15% | 0.24% | Q2 2016 | Q4 2018 | 11 | |
| PTX | PERNIX THERAPEUTICS HL... | 10 | 10 | 0.21% | 1.87% | 5.22% | Q2 2014 | Q3 2016 | 10 |
| EVAR | LOMBARD MED INC | 10 | 10 | 0.09% | 0.64% | 1.84% | Q2 2014 | Q3 2016 | 10 |
| SRNE | SORRENTO THERAPEUTICS INC | 9 | 9 | 0.01% | 2.66% | 5.56% | Q4 2013 | Q4 2015 | 9 |
| PTXTQ | PERNIX THERAPEUTICS HL... | 9 | 9 | 0.02% | 0.09% | 0.14% | Q4 2016 | Q4 2018 | 9 |
| CTLT | CATALENT INC | 8 | 8 | 2.57% | 4.52% | 8.55% | Q3 2014 | Q2 2016 | 8 |
| DERM | DERMIRA INC | 7 | 7 | 0.71% | 3.18% | 4.90% | Q4 2014 | Q2 2016 | 7 |
| SYRS | SYROS PHARMACEUTICALS,... | 7 | 7 | 0.98% | 1.70% | 3.89% | Q2 2016 | Q4 2017 | 7 |
| ROKA | ROKA BIOSCIENCE INC | 7 | 7 | 0.07% | 0.61% | 2.19% | Q3 2014 | Q1 2016 | 7 |
| CYNA | CYNAPSUS THERAPEUTICS ... | 5 | 5 | 2.43% | 4.25% | 9.29% | Q3 2015 | Q3 2016 | 5 |
| MEIP | MEI PHARMA INC | 5 | 5 | 0.00% | 1.81% | 5.98% | Q1 2014 | Q1 2015 | 5 |
| DRTX | DURATA THERAPEUTICS INC | 4 | 4 | 4.99% | 16.95% | 28.35% | Q4 2013 | Q3 2014 | 4 |
| PERNIX THERAPEUTICS HL... | 3 | 3 | 0.16% | 0.24% | 0.32% | Q3 2015 | Q1 2016 | 3 | |
| Q | Quintiles Transnationa... | 2 | 2 | 40.72% | 46.19% | 51.65% | Q4 2013 | Q1 2014 | 2 |
| AMBI | AMBIT BIOSCIENCES CORP | 2 | 2 | 3.30% | 4.11% | 4.93% | Q2 2014 | Q3 2014 | 2 |
| ENTL | ENTELLUS MED INC | 2 | 2 | 1.60% | 2.08% | 2.55% | Q3 2017 | Q4 2017 | 2 |
| ICPT | Intercept Pharmaceuticals | 1 | 1 | 5.75% | 5.75% | 5.75% | Q4 2013 | Q4 2013 | 1 |
| MEI Pharma, Inc. | 1 | 1 | 3.79% | 3.79% | 3.79% | Q4 2013 | Q4 2013 | 1 | |
| ZLTQ | ZELTIQ AESTHETICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2014 | Q2 2014 | 1 |
| CEMP | CEMPRA INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2014 | Q2 2014 | 1 |
| PTX | PERNIX THERAPEUTICS HL... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2014 | Q2 2014 | 1 |
Download | |||||||||
The securities at the top of the list , including TRANSENTERIX INC., CHIMERIX INC., and ADMA BIOLOGICS INC., are the highest-conviction holdings of Aisling Capital LLC.
The conviction is calculated by counting the number of quarters a security has been reported by Aisling Capital LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Aisling Capital LLC owns currently or has owned in the past.